Current Pharmaceutical Research
Not a member yet
40 research outputs found
Sort by
Nanomedicine Approaches to Overcome Barriers in Pulmonary Drug Delivery for Respiratory Diseases
Delivering drugs through the lungs is a promising method for treating respiratory conditions, offering quick absorption into the bloodstream and targeted therapeutic effects due to the lungs’ distinct structure. However, obstacles like mucociliary clearance, activity of alveolar macrophages, and variations among patients can limit the success of traditional treatments. Nanomedicine has become a cutting-edge solution to these challenges, using diverse nanocarriers such as liposomes, polymeric nanoparticles, and hybrid systems to improve drug stability, availability, and precision in delivery. These systems enable controlled release, enhanced solubility, and reduced side effects on the rest of the body. Moreover, multifunctional nanocarriers combine diagnostic and therapeutic roles, paving the way for personalized treatments for diseases like asthma, COPD, pulmonary fibrosis, and lung infections. Despite its potential, issues like large-scale production, regulatory hurdles, and ensuring compatibility with the body remain challenges. This review explores how nanomedicine addresses barriers in lung drug delivery, highlights its role in treating respiratory diseases, and looks at opportunities for clinical advancement
Nanotechnology for Diabetes Management: Transforming Anti-diabetic Drug Delivery Systems
To prevent major complications, people with chronic diabetes mellitus, a metabolic condition characterised by increased blood sugar, require continuous care. Although current pharmacological treatments, such as insulin and oral hypoglycemic agents, are effective, they are often limited by poor bioavailability, short half-life, and systemic side effects. Drug delivery systems based on nanotechnology provide encouraging answers to these problems, allowing for the targeted, precise, and regulated administration of anti-diabetic medications. In order to improve therapeutic efficacy, decrease the frequency of administration, and increase drug bioavailability, nanoparticles, liposomes, nanogels, and microneedles are becoming important technologies. For example, liposomes increase the solubility and durability of hydrophobic medications, whereas nanoparticles can shield medications from deterioration and enable continuous release. In response to hyperglycemia, nanogels that are engineered to react to particular stimuli, such as pH or glucose levels, allow regulated medication release that mimics the body\u27s normal production of insulin. Insulin and other anti-diabetic medications can be delivered painlessly via microneedles, a minimally invasive substitute for conventional injections. Notwithstanding these developments, issues with scalability, cost, regulatory approval, and long-term safety still affect the clinical translation of these technologies. This study looks at the state of diabetic medication delivery systems based on nanotechnology, emphasising how they have the potential to transform treatment approaches and enhance patient outcomes. Future research should focus on overcoming these barriers, conducting clinical trials, and exploring new nanomaterials to maximize the therapeutic potential of these systems
Hydrogel Microneedles: A Breakthrough in Disease Treatment and Drug Delivery Systems
A revolutionary development in medication administration and illness treatment, hydrogel microneedles provide a painless, effective, and less invasive substitute for conventional techniques. These Hydrogel microneedles, which are made of hydrophilic, biocompatible polymers, expand when inserted into the skin, allowing for controlled medication release and interstitial fluid extraction for diagnostic purposes. This special feature tackles the main issues with traditional administration methods, such as hypodermic needle hazards, limited bioavailability, and patient discomfort. Because of their great versatility, hydrogel microneedles can deliver a variety of treatments, including proteins, nucleic acids, small compounds, and vaccinations. They are perfect for real-time monitoring and tailored therapy since they can be integrated with drug reservoirs and biosensors. These systems improve patient compliance, decrease the frequency of administration, and increase the effectiveness of therapies for long-term illnesses including cancer and diabetes. Advances in fabrication techniques, including photolithography, micromolding, and 3D printing, have enabled the production of robust and scalable Hydrogel microneedles designs tailored to specific applications. Beyond drug delivery, hydrogel microneedles are used in immunotherapy, glucose monitoring, insulin delivery, wound healing, and cosmetic treatments, showcasing their broad applicability. Despite their potential, challenges such as high production costs, variability in performance, and regulatory hurdles need to be addressed for widespread adoption. Ongoing research aims to improve their payload capacity, stability of sensitive biomolecules, and integration with wearable devices. Hydrogel microneedles hold immense promise for the future, combining therapeutic and diagnostic functionalities for theranostic applications. As material science and manufacturing technologies advance, hydrogel microneedles are poised to revolutionize healthcare by providing pain-free, efficient, and sustainable solutions for drug delivery and disease management
Berberine in Breast Cancer Management: Molecular Mechanisms, Therapeutic Applications, and Future Directions
Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. While conventional therapies such as surgery, chemotherapy, radiation, hormonal, targeted, and immune therapy have improved survival rates, drug resistance and recurrence remain major challenges. Berberine (BBR), a natural isoquinoline alkaloid found in various medicinal plants, has emerged as a promising candidate in integrative oncology due to its diverse pharmacological properties. This review summarizes the anticancer potential of BBR in breast cancer, particularly its ability to inhibit proliferation, induce apoptosis, regulate autophagy, suppress metastasis, and modulate key signaling pathways such as AMPK, PI3K/Akt/mTOR, Wnt/β-catenin, and MAPK/ERK. Furthermore, BBR’s molecular targets—including microRNAs, p53, Ephrin-B2, and SIK3—highlight its multi-targeted mode of action. Notably, BBR demonstrates selective toxicity against cancer cells while sparing normal tissues. These findings support BBR’s potential as a complementary agent to enhance the efficacy of standard therapies and overcome drug resistance. Further clinical studies are necessary to establish its safety, optimal dosing, and therapeutic integration in breast cancer management
Mouth-Dissolving Films: A Novel Approach for Oral Drug Delivery in Diabetic Management
For the administration of several pharmacologicals, the oral route is considered one of the most practical methods of drug administration, as it accommodates various dosage forms, including tablets, syrups, capsules, emulsions, and suspensions. Mouth Dissolving Drug Delivery Systems have created several fast-dissolving preparations, such as MDT and mouth dissolving film. The hydrophilic polymer makes oral thin films, an innovative dosage form designed to dissolve quickly in the buccal cavity. when it is placed in the mouth, because it is less expensive to produce, mouth dissolving film is better than mouth dissolving tablets. Oral films help overcome swallowing difficulties commonly experienced by both elderly and paediatric patients with tablets and capsules. It also has other benefits, including self-administration and rapid dissolution. This dosage form allows for rapid absorption, making it highly versatile. The current study aims to highlight various polymers, their concentrations, and their applications. Additionally, it explores the role of plasticizers, sweeteners, polymers, and different techniques used in the formulation of oral films, along with the key parameters for their evaluation
Emerging Strategies for Targeted Drug Delivery across the Blood–Brain Barrier in Neurological Disorder
The Blood–Brain Barrier is an obstacle in the treatment of neurological disorders since it selectively only allows some substances to pass through. Its poor permeability greatly limits access of certain therapeutic agents in the brain. In order to successfully treat glioblastoma, Parkinson\u27s disease, Alzheimer\u27s disease, and other illnesses of the central nervous system, it will be crucial to overcome the Blood Brain Barrier. Recent developments in targeted drug delivery systems have presented promising potential for this challenge. Emerging strategies include nanotechnology-based systems, receptor-mediated transport, cell-penetrating peptides, focused ultrasound, and advanced carrier designs. Nanotechnology-based systems, including liposomes, polymeric nanoparticles, and SLNs, offer controlled drug release and improved bioavailability, while surface modifications enhance Blood–Brain Barrier penetration through receptor-specific targeting. By conjugating medications to ligands that attach to certain receptors on Blood–Brain Barrier endothelial cells, receptor-mediated transport strategies facilitate active transport across the barrier. Cell-penetrating peptides are short peptides that have been utilised to deliver a variety of medicinal substances because they can pass through cell membranes. When combined with microbubbles, focused ultrasounds can momentarily breach the Blood Brain Barrier, enabling tailored medication administration without the need for invasive procedures. In addition, sophisticated carrier designs like dendrimers and mesoporous silica nanoparticles enhance drug stability and provide prolonged release. These strategies have great promise in improving drug delivery into the brain, treatment efficacy, and minimizing side effects
Exploring the Role of Herbal Remedies and Alternative Therapies in Managing Vitiligo: A Comprehensive Review
Vitiligo is a persistent skin disorder characterized by the loss of pigmentation due to the destruction of melanocytes, which are responsible for producing skin color. Although the exact cause is not fully understood, it is believed to result from a combination of genetic predisposition, autoimmune responses, and environmental factors like stress or trauma. The condition leads to the formation of depigmented patches on the skin, hair, and mucous membranes. While not life-threatening, vitiligo often causes considerable psychological distress, including feelings of embarrassment, shame, and social stigma, which can significantly affect an individual’s emotional health and quality of life. Existing treatment options, such as corticosteroids, phototherapy, and surgical procedures, offer varying levels of success, but no definitive cure has been found. This has sparked increased interest in alternative treatments, particularly herbal remedies. Herbal substances like Ginkgo biloba, Curcumin, and Green Tea are being studied for their potential to reduce oxidative stress, regulate the immune system, and encourage melanocyte regeneration, offering promising non-pharmaceutical solutions for managing vitiligo. This paper offers a thorough overview of vitiligo, including its pathophysiology, classification, and epidemiology. It also examines current treatment methods, with a focus on the potential advantages of herbal remedies. Furthermore, the paper discusses ongoing research into molecular therapies aimed at improving melanocyte function and restoring pigmentation. Given the persistent nature of vitiligo and its significant psychological impact, continued exploration of both conventional and alternative treatments is vital for enhancing patient care. As research advances, new treatment approaches may provide more effective solutions for managing vitiligo and reducing its emotional and social effects. The emerging role of herbal remedies is also highlighted, positioning them as promising alternatives or supplements to conventional treatments
Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine
Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine. Biofilmassociated infections pose significant challenges to traditional antimicrobial therapies due to their inherent resistance mechanisms and protective extracellular matrix. Nanomedicine offers transformative solutions by providing innovative strategies to target, penetrate, and disrupt biofilms effectively. Recent advancements in nanotechnology have enabled the development of multifunctional nanocarriers, hybrid nanoparticles, and stimuli-responsive systems designed to enhance drug delivery and reduce bacterial resistance. These systems facilitate precise targeting of biofilms, leveraging mechanisms such as enzyme-mediated degradation, quorum-sensing inhibition, and environment-responsive drug release. Furthermore, personalized medicine approaches, integrating pathogen-specific diagnostics and AI-driven optimization, hold promise for tailoring treatments to individual patient needs. Despite these breakthroughs, challenges such as toxicity concerns, scalability, and regulatory hurdles remain. Overcoming these barriers through interdisciplinary collaboration and continued research is essential to translate nanomedicine from laboratory success to clinical application. This paradigm shift in antimicrobial therapy has the potential to revolutionize the treatment of biofilm-related infections, significantly reducing global healthcare burdens and improving patient outcomes
Peptide-Based Therapeutics in Fungal Infections: Challenges and Innovations
In light of the growing resistance to antifungal medications, peptide-based therapies have become a viable substitute for treating fungal infections. These peptides, derived from various natural sources or synthesized in the laboratory, exhibit unique mechanisms of action, such as membrane disruption, inhibition of fungal metabolism, and modulation of immune responses. Despite their potential, several challenges remain, including issues with stability, bioavailability, and selectivity. Advances in peptide design, including the cyclization and the addition of artificial amino acids, have improved their therapeutic properties. Additionally, novel delivery systems, such as nanoparticles and liposomes, are being explored to enhance the efficacy and targeted delivery of these peptides. This review explores the characteristics, applications, and challenges of peptide-based antifungal therapies, while also discussing recent innovations in the field. With continued research and development, peptide-based therapeutics could offer a significant contribution to the treatment of fungal infections
Formulation and Evaluation of a Multicomponent Herbal Shampoo for Enhanced Hair and Scalp Health
The study focuses on the formulation and evaluation of a novel herbal shampoo as a natural alternative to synthetic commercial products. Synthetic shampoos, though effective, are often associated with adverse effects such as scalp irritation, hair dryness, and hair fall due to the presence of harsh detergents and chemical additives. In response, the present research aimed to develop a safe, eco-friendly, and effective herbal formulation using traditional medicinal plants, including bhringraj, soap nut, shikakai, amla, Senna, hibiscus, aloe vera, lemon juice, rose oil, and gelatin. The shampoo was prepared through Soxhlet extraction and evaluated for its physicochemical and functional properties. Tests performed included physical appearance, pH measurement, per cent solid content, wetting time, dirt dispersion, foaming ability, foam stability, and surface tension analysis. Results revealed that the herbal shampoo had a mildly acidic pH (6.5), consistent with ideal hair care standards. Solid content was measured at 1%, indicating a light formulation. The wetting time was three seconds, demonstrating quick cleansing action, while the dirt dispersion test showed adequate cleansing capacity. Foaming studies confirmed moderate foam stability, and surface tension measurements (30–40 dynes/cm) highlighted vigorous surfactant activity comparable to synthetic shampoos. Overall, the formulated herbal shampoo demonstrated desirable qualities, including effective cleansing, good surface activity, and environmental safety, validating the potential of herbal alternatives in the personal care industry. The findings support consumer preferences for natural, safe, and sustainable products that do not compromise performance or quality